Camp4 Therapeutics (CAMP) Interest Expenses (2023 - 2024)
Camp4 Therapeutics' (CAMP) quarterly Interest Expenses came in at -$145000.0 in Q4 2024, down 274.7% year-on-year from $83000.0 in Q1 2024, and down 333.87% quarter-over-quarter from $62000.0 in Q3 2024.
Camp4 Therapeutics (CAMP) Interest Expenses (2023 - 2024) Analysis & Trends
Camp4 Therapeutics has disclosed Interest Expenses across 2 years of filings, most recently posting -$145000.0 for Q4 2024.
- Interest Expenses for Q4 2024 came in at -$145000.0, down 274.7% year-over-year; the trailing twelve-month figure through Sep 2025 was -$145000.0 (down 200.0% YoY), and the FY2025 annual result was $192000.0, up 481.82% from the prior year.
- Interest Expenses came in at -$145000.0 for Q4 2024 at Camp4 Therapeutics, down from $62000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $83000.0 in Q4 2023 to a low of -$145000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -5.58 Mn |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -145,000.00 |
| Dec 31, 2024 | -145,000.00 |
| Sep 30, 2024 | 62,000.00 |
| Sep 30, 2024 | 62,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Sep 30, 2023 | 47,000.00 |
| Sep 30, 2023 | 47,000.00 |